Status:
COMPLETED
Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted in Asia. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.
Eligibility Criteria
Inclusion
- Type 1 or type 2 diabetes mellitus
Exclusion
- Subjects who are unlikely to comply with the protocol
- Subjects who are currently being treated with Levemir®
- Subjects who previously were enrolled into the study
- Subjects with hypersensitivity to Levemir® or any of its excipients
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
1531 Patients enrolled
Trial Details
Trial ID
NCT00700765
Start Date
January 1 2008
End Date
July 1 2008
Last Update
October 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Jakarta, Indonesia, 12520